EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ERBB2 amplification in gastric cancer: a genomic insight into ethnic disparities

Muhammad Bilal Mirza iD, Jungyoon Choi, Paula Marincola Smith, Jordan J Baechle, Chandrasekhar Padmanabhan, Andreana N Holowatyj, Shailja C Shah, Xingyi Guo iD, Kamran Idrees iD

JNCI: Journal of the National Cancer Institute · 2024

DOI: 10.1093/jnci/djae147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Muhammad Bilal Mirza und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Gene Amplification, Health Status Disparities, Erb-b2 Receptor Tyrosine Kinases, Stomach Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH, NICHD NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overall, gastric adenocarcinoma (GC) incidence rates have declined in recent years, but racial and ethnic disparities persist. Individuals who identify as Hispanic/Spanish/Latino are diagnosed with GC at younger ages and have poorer outcomes than non-Hispanic individuals. However, our understanding of GC biology across racial/ethnic groups remains limited. We assessed tumor genomic patterns by race/ethnicity among 1019 patients with primary GC in the American Association for Cancer Research (AACR) Project GENIE Consortium. Hispanic individuals presented with significantly higher rates of ERBB2/HER2 amplification vs other racial/ethnic groups (Hispanic: 13.9% vs 9.8% non-Hispanic White, 8.1% non-Hispanic Asian, and 11.0% non-Hispanic Black; P < .001, FDR adjusted q < 0.001). Hispanic patients also had higher odds of an ERBB2 amplification vs non-Hispanic Whites in adjusted models (OR = 2.52, 95%CI = 1.20 to 5.33, P = .015). These findings underscore the important role of genomic factors in GC disparities. Ensuring equitable access to genomic profiling and targeted therapies, such as trastuzumab for HER2-overexpressing GC, is a promising avenue to mitigate GC disparities and improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene AmplificationHealth Status DisparitiesErb-b2 Receptor Tyrosine KinasesStomach NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedAdenocarcinomaEthnicityGenomicsHispanic or LatinoUnited StatesWhiteBlack or African American

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Division of Oncology/Hematology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea.
  • Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
  • Department of Medicine, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • GI Section, VA San Diego Health System, La Jolla, CA, USA.
  • Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA.

ORCID-Profile: Muhammad Bilal Mirza, Xingyi Guo, Kamran Idrees

Förderung

  • NIH
  • NICHD NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • CSRD VA
  • National Institutes of Health
  • NICHD
  • National Cancer Institute

Zitieren

APA

Mirza, M. B., Choi, J., Marincola Smith, P., Baechle, J. J., Padmanabhan, C., Holowatyj, A. N., Shah, S. C., Guo, X., & Idrees, K. (2024). ERBB2 amplification in gastric cancer: a genomic insight into ethnic disparities. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae147

Vancouver

Mirza MB, Choi J, Marincola Smith P, Baechle JJ, Padmanabhan C, Holowatyj AN, et al. ERBB2 amplification in gastric cancer: a genomic insight into ethnic disparities. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae147

BibTeX
@article{Mirza2024,
  author = {Mirza, Muhammad Bilal and Choi, Jungyoon and Marincola Smith, Paula and Baechle, Jordan J and Padmanabhan, Chandrasekhar and Holowatyj, Andreana N and Shah, Shailja C and Guo, Xingyi and Idrees, Kamran},
  title = {ERBB2 amplification in gastric cancer: a genomic insight into ethnic disparities},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2024},
  doi = {10.1093/jnci/djae147}
}
Kostenlos starten →